© 2026 WEKU
Lexington's Choice for NPR
Support WEKU!
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
The 1850 campaign is replacing lost federal funds one supporter at a time. Thanks to our listeners and supporters, we are now just 292 away from reaching this goal of 1850 new supporters donating at least $10 a month. Click here to join the campaign!

What the FDA's rejection of Moderna's flu shot means for the future of vaccines

NPR | By Sydney Lupkin,
Ayesha Rascoe
Published February 15, 2026 at 8:05 AM EST

The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.

Copyright 2026 NPR
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.
See stories by Sydney Lupkin
Ayesha Rascoe
Ayesha Rascoe is a White House correspondent for NPR. She is currently covering her third presidential administration. Rascoe's White House coverage has included a number of high profile foreign trips, including President Trump's 2019 summit with North Korean leader Kim Jong Un in Hanoi, Vietnam, and President Obama's final NATO summit in Warsaw, Poland in 2016. As a part of the White House team, she's also a regular on the NPR Politics Podcast.
See stories by Ayesha Rascoe
Support nonprofit, fact-based public service journalism
WEKU depends on support from those who view and listen to our content. There's no paywall here. Please support WEKU with your donation.
Contribute now
Related Content